Page last updated: 2024-12-08

trimeprazine tartrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID441236
SCHEMBL ID719590
MeSH IDM0098319

Synonyms (61)

Synonym
41375-66-0
trimeprazine tartrate [usp]
unii-362nw1ld6z
nsc 757358
362nw1ld6z ,
trimeprazine tartrate
alimemazine tartrate
panectyl
skf 5277
theralene
theralen
10-(3-(dimethylamino)-2-methylpropyl)phenothiazine tartrate (2:1)
repeltin
10h-phenothiazine-10-propanamine n,n,beta-trimethyl-, (r-(r*,r*))-2,3-dihydroxybutanedioate (2:1)
alimemazin (rr)-tartrat
therafene
vallergan
vanectyl
phenothiazine, 10-(3-(dimethylamino)-2-methylpropyl)-, tartrate (2:1)
einecs 224-368-9
nsc-17475
4330-99-8
alimezine (tn)
trimeprazine tartrate (usp)
alimemazine tartrate (jp17)
D02245
nsc-757358
dtxcid1025560
trimeprazine hemitartrate salt
S5730
SCHEMBL719590
10-[3-(dimethylamino)-2-methylpropyl]phenothiazine tartrate
methylpromazine tartrate
alimemazine hemitartrate
trimeprazine hemitartrate
trimeprazine tartrate [green book]
alimemazine tartrate [mart.]
10h-phenothiazine-10-propanamine n,n,.beta.-trimethyl-, (r-(r*,r*))-2,3-dihydroxybutanedioate (2:1)
alimemazine tartrate [jan]
trimeprazine tartrate [usp impurity]
alimemazine tartrate [who-dd]
trimeprazine tartrate [mi]
10-[3-(dimethylamino)-2-methylpropyl]phenothiazine tartrate (2:1)
trimeprazine tartrate [vandf]
alimemazine hemitartrate [ep monograph]
trimeprazine tartrate [usp monograph]
trimeprazine tartrate [orange book]
trimeprazine tartrate 1.0 mg/ml in methanol (as free base)
BS-17283
mfcd00242594
CCG-270431
Q27256512
T70916
AKOS037649218
alimemazinehemitartrate
2,3-dihydroxybutanedioic acid;n,n,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine
alimemazine for system suitability
trimeprazine tartrate (usp impurity)
trimeprazine tartrate (usp monograph)
alimemazine tartrate (mart.)
alimemazine hemitartrate (ep monograph)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (82.61)18.7374
1990's2 (8.70)18.2507
2000's0 (0.00)29.6817
2010's2 (8.70)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.73 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index40.78 (26.88)
Search Engine Supply Index2.13 (0.95)

This Compound (31.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (12.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (84.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]